Clinical Trial Update: Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris [Phase 4]

View source ↗

Summary

A Phase 4 study comparing tazarotene cream 0.1% to adapalene gel 0.3% for moderate-to-severe facial acne vulgaris was terminated with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Adapalene Gel 0.3% (adapalene)
• Tazarotene cream 0.1% (Tazarotene)

Snippet

Sponsor: Allergan | Conditions: Acne Vulgaris | Phase 4 | Status: TERMINATED | Results posted: 2012-09-12